Hamburg also urged Indian regulators to work closely
with their foreign peers.
Hamburg was speaking to reporters at the end of a visit to India
which follows FDA decisions to ban the shipment of drugs to the
United States from plants of leading Indian drugmakers including
Ranbaxy Laboratories Ltd and Wockhardt Ltd.
During a visit that started on February 10, Hamburg met the Indian
drugs regulator and health ministry officials as well as executives
of local drugmakers.
(Reporting by Sumeet Chatterjee and Zeba
Siddiqui; editing by Christopher Cushing and Miral Fahmy)
[© 2014 Thomson Reuters. All rights
Copyright 2014 Reuters. All rights reserved. This material may not be published,
broadcast, rewritten or redistributed.